Danicopan Plus Eculizumab Can Improve Outcomes for Patients With Paroxysmal Nocturnal Hemoglobinuria
Researchers sought to determine whether adding danicopan to eculizumab would improve outcomes for patients with PNH.
Researchers sought to determine whether adding danicopan to eculizumab would improve outcomes for patients with PNH.
Researchers sought to determine the incidence of bleeding and thrombotic events in patients receiving CAR-T therapy.
Researchers sought to determine whether a patient similarity network would be able to identify patients based on their gene expression to help apply targeted therapies.
Researchers sought to determine whether patients with subtypes of DLBCL would have different responses to ibrutinib plus R-CHOP vs R-CHOP alone.
Researchers sought to determine whether adding daratumumab to carfilzomib would help prevent cardiovascular adverse events in patients with relapsed/refractory multiple myeloma.
Researchers sought to determine the impact of GST polymorphisms on the risk of B-ALL.
Researchers sought to determine whether sex differences may lead to different clinical outcomes in patients with SCD.
Researchers sought to determine whether patients with hemophilia A would be at higher risk of bleeding events when participating in high-collision physical activity.
Researchers sought to determine whether patients with hemoglobinopathy would have a higher mortality rate from infection with COVID-19 than the general population.
Researchers sought to determine the long-term adverse events that occur as a result of pediatric ALL.